Lv5
820 积分 2023-11-03 加入
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
20小时前
待确认
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
2天前
已完结
Investigating the origins of recent pharmaceutical innovation
8天前
已完结
Cleavable linkers in antibody–drug conjugates
24天前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
24天前
已完结
Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
29天前
已完结
Role of Immunotherapy in Triple-Negative Breast Cancer
29天前
已完结
Epidemiology of Triple-Negative Breast Cancer
29天前
已完结
Cancer incidence and mortality in China, 2022
1个月前
已完结
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
1个月前
已完结
皖公网安备34019202002308
